Boston Scientific Hit by Cyberattack. Stock Fell Wednesday
Boston Scientific said a cyberattack disrupted operations and shipping as the FDA raised concerns about a catheter tip separation risk.
- Boston Scientific detected a "cybersecurity incident" on Aug. 25, disrupting global operations, while separately recalling its ENROUTE Transcarotid Neuroprotection System following FDA concerns about potential arterial sheath tip separation.
- The breach disrupted access to business applications and order processing, prompting the $69bn company to engage third-party cybersecurity experts to help assess and contain the threat.
- Following the dual disclosures, shares fell 3.39% on Wednesday, as Boston Scientific noted the incident impacted its ability to process and ship customer orders, with Cork-based workers instructed to work from home.
- "While the company is working diligently to restore affected functions and systems access, the timeline for a full restoration is not yet known," Boston Scientific said; the investigation remains ongoing.
- This breach joins recent attacks on medical technology firms including Medtronic and Abbott Laboratories, with research showing 80pc of affected medical devices report significant impacts on patient care.
24 Articles
24 Articles
Boston Scientific says cyberattack is causing a ‘global disruption’ to medical device operations
Boston Scientific confirmed a cyberattack disrupting global operations and IT systemsIncident response activated; SEC filing notes ongoing impact on order processing and shippingNature of attack undisclosed, but disruption suggests ransomware; no group claimed responsibility yetBoston Scientific, a US-based global medical technology company, has confirmed it was the target of a cyberattack which disrupted operations worldwide and disrupted its I…
Cyberattack on Boston Scientific causes global ops disruption Nicole.Raleigh Thu, 27/08/2026
Stock Market Today, Aug. 26: Boston Scientific Shares Fall 5% on Cybersecurity Incident and Product Recall
Boston Scientific (NYSE:BSX), a global medical device maker, closed at $48.17, down 3.38%. Premarket reports said a cybersecurity incident disrupted global operations and shipping. The company also announced a product recall for certain types of its percutaneous catheters, further weighing on the stock. Investors are watching how quickly the company restores its systems and whether the recall exacerbates the interruption. Trading volume reached …
Coverage Details
Bias Distribution
- 69% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
